Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Biome Australia Ltd ( (AU:BIO) ) has issued an update.
Biome Australia Limited has announced an upcoming Investor Webinar scheduled for March 7, 2025, where the company’s Managing Director, Blair Vega Norfolk, will discuss the half-yearly results. This event signifies Biome’s commitment to engaging with investors and stakeholders, potentially impacting its market positioning by highlighting its recent performance and strategic initiatives.
More about Biome Australia Ltd
Biome Australia Limited is a microbiome health company that develops, licenses, and markets innovative live biotherapeutics (probiotics) and complementary medicines. Founded in 2018, the company partners with leading organizations in microbiome research to create products like Activated Probiotics®, which are supported by clinical research and aim to address health concerns such as low mood, sleep issues, bone health, iron malabsorption, mild eczema, and IBS. Biome distributes its products locally and internationally, focusing on practitioner-only distribution to educate health professionals on the systemic health effects of gut microbiota.
YTD Price Performance: -5.08%
Average Trading Volume: 499,778
Technical Sentiment Consensus Rating: Sell
Learn more about BIO stock on TipRanks’ Stock Analysis page.